National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No. 1) (PB 80 of 2016) (Cth)
PB 80 of 2016
National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No.1)
National Health Act 1953
I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated: 31 August 2016
PENNY SHAKESPEARE
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
Name of Determination
(1) This Determination is the National Health (Weighted average disclosed price – October 2016 reduction day) Amendment Determination 2016 (No.1).
(2) This Determination may also be cited as PB 80 of 2016.
Commencement
This Determination commences on the day after it is registered.
Amendments to PB 39 of 2016
Schedule 1 amends the National Health (Weighted average disclosed price – October 2016 reduction day) Determination 2016 (PB 39 of 2016).
Schedule 1 Amendments
[1] Schedule 1
after:
| 327 | Celecoxib | Capsule 200 mg | Oral | Terry White Chemists Celecoxib | 9.42 |
insert:
| 327A | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Celapram | 0.90 |
| 327B | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Citalopram Actavis | 0.90 |
| 327C | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Citalopram-GA | 0.90 |
| 327D | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Talam | 0.90 |
[2] Schedule 1
omit:
| 328 | Cisplatin | I.V. injection 100 mg in 100 mL | Injection | Cisplatin Ebewe | 13.45 |
| 329 | Cisplatin | I.V. injection 100 mg in 100 mL | Injection | Hospira Pty Limited | 13.45 |
| 330 | Cisplatin | I.V. injection 50 mg in 50 mL | Injection | Hospira Pty Limited | 7.26 |
[3] Schedule 1
omit:
| 442 | Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusamide | 4.15 |
| 443 | Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusopt | 4.15 |
[4] Schedule 1
omit:
| 444 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor | 11.10 |
| 445 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | 11.10 |
| 446 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Dorzolamide/Timolol Sandoz 20/5 | 11.10 |
substitute:
| 444 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor | 12.08 |
| 445 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | 12.08 |
| 446 | Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Dorzolamide/Timolol Sandoz 20/5 | 12.08 |
[5] Schedule 1
omit:
| 504 | Epirubicin | Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/intravesical | Epirubicin ACT | 23.36 |
| 505 | Epirubicin | Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL | Injection/intravesical | Hospira Pty Limited | 23.36 |
| 506 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical | DBL Epirubicin Hydrochloride Injection | 46.67 |
| 507 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical | Epirubicin ACT | 46.67 |
| 508 | Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical | Epirubicin Kabi | 46.67 |
| 509 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/intravesical | Epirubicin ACT | 11.70 |
| 510 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/intravesical | Epirubicin SZ | 11.70 |
| 511 | Epirubicin | Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL | Injection/intravesical | Hospira Pty Limited | 11.70 |
[6] Schedule 1
after:
| 617 | Flucloxacillin | Powder for injection 1 g (as sodium) | Injection | Hospira Pty Limited | 4.95 |
insert:
| 617A | Flucloxacillin | Powder for injection 500 mg (as sodium) | Injection | Flubiclox | 1.49 |
[7] Schedule 1
after:
| 636 | Fluorouracil | Injection 500 mg in 10 mL | Injection | Hospira Pty Limited | 16.09 |
insert:
| 636A | Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | 32.18 |
[8] Schedule 1
omit:
| 826 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Hospira Pty Limited | 13.62 |
| 827 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinoccord | 13.62 |
| 828 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Alphapharm | 13.62 |
| 829 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Ebewe | 13.62 |
| 830 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Kabi | 13.62 |
| 831 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan MYX | 13.62 |
| 832 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Omegapharm Irinotecan | 13.62 |
| 833 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL | Injection | Irinotecan Ebewe | 40.85 |
| 834 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinoccord | 5.45 |
| 835 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Alphapharm | 5.45 |
| 836 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Ebewe | 5.45 |
| 837 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Omegapharm Irinotecan | 5.45 |
| 838 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Hospira Pty Limited | 68.09 |
| 839 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Actavis 500 | 68.09 |
| 840 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Alphapharm | 68.09 |
| 841 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Ebewe | 68.09 |
[9] Schedule 1
after:
| 1783 | Sumatriptan | Tablet 50 mg (as succinate) | Oral | Terry White Chemists Sumatriptan | 2.69 |
insert:
| 1783A | Tamoxifen | Tablet 10 mg (as citrate) | Oral | Genox 10 | 10.21 |
[10] Schedule 2
omit:
| 295 | Ceftriaxone | Powder for injection 500 mg (as sodium) | Injection | Ceftriaxone-AFT | 0.99 |
[11] Schedule 2
omit:
| 371 | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Celapram | 1.06 |
| 372 | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Citalopram Actavis | 1.06 |
| 373 | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Citalopram-GA | 1.06 |
| 374 | Citalopram | Tablet 10 mg (as hydrobromide) | Oral | Talam | 1.06 |
[12] Schedule 2
after:
| 489 | Docetaxel | Solution concentrate for I.V. infusion 80 mg in 8 mL | Injection | Docetaxel Sandoz | 14.81 |
insert:
| 489A | Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusamide | 9.22 |
| 489B | Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusopt | 9.22 |
[13] Schedule 2
omit:
| 499 | Doxycycline | Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Doryx | 1.57 |
| 500 | Doxycycline | Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | 1.57 |
[14] Schedule 2
omit:
| 584 | Flucloxacillin | Powder for injection 500 mg (as sodium) | Injection | Flubiclox | 2.66 |
[15] Schedule 2
omit:
| 592 | Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | 46.16 |
[16] Schedule 2
after:
| 1055 | Morphine | Capsule containing morphine sulfate 90 mg (controlled release) | Oral | MS Mono | 26.12 |
insert:
| 1055A | Morphine | Injection containing morphine hydrochloride 10 mg in 1 mL | Injection | Morphine Juno | 6.34 |
| 1055B | Morphine | Injection containing morphine hydrochloride 100 mg in 5 mL | Injection | Morphine Juno | 26.97 |
| 1055C | Morphine | Injection containing morphine hydrochloride 20 mg in 1 mL | Injection | Morphine Juno | 9.71 |
| 1055D | Morphine | Injection containing morphine hydrochloride 50 mg in 5 mL | Injection | Morphine Juno | 16.19 |
[17] Schedule 2
after:
| 1535 | Tacrolimus | Capsule 0.5 mg (once daily prolonged release) | Oral | Prograf XL | 37.52 |
insert:
| 1535A | Tacrolimus | Capsule 0.75 mg | Oral | Tacrolimus Sandoz | 170.29 |
[18] Schedule 2
after:
| 1540 | Tacrolimus | Capsule 1 mg (once daily prolonged release) | Oral | Prograf XL | 136.30 |
insert:
| 1540A | Tacrolimus | Capsule 2 mg | Oral | Tacrolimus Sandoz | 454.10 |
[19] Schedule 2
omit:
| 1546 | Tamoxifen | Tablet 10 mg (as citrate) | Oral | Genox 10 | 12.15 |
0
0
0